Oberlunkhofen, Aargau, Switzerland
As General Manager at Bristol Myers Squibb, I lead the markets in Europe, Latin America, Russia, and North Africa, which fall under the Local Representative/Distributor Markets (LR) category. I am responsible for the development and implementation of commercial strategies for our innovative oncology/hematology/immunology products, which represent groundbreaking treatments for patients. I have about 20 years of experience in the biopharma industry, both at BMS and at Celgene, where I worked as Director, CAR-T Commercialization Lead, and Commercial Director for international markets. In these roles, I closely collaborated with clinical, regulatory, medical, and scientific teams to ensure the safety, quality, and efficacy of our products. I have also led and supported several successful product launches, partnerships, and contracts across different regions and therapeutic areas. I am a trained biologist with a Master's degree from the University of Basel and have in-depth knowledge in oncology, virology, and pharmacovigilance. My mission is to improve the lives of patients with serious diseases by providing them with access to the best available treatment options. I am a motivated, collaborative, and solution-oriented leader who is committed to diversity, inclusion, and innovation. I am fluent in German, English, French, and Spanish and am always ready to take on new challenges and learn from others.
Leading the Local Representative Markets globally - 41 countries: Latin America, Central Eastern Europe, Russia and Middle East & Africa
Responsible for direct Management of 8 Sales Representatives. Track record turn-around phase.
Responsible for all brand management activities in multiple indications. Business planning leadership in highly cross-functional team.
Responsible for all brand management activities in multiple indications. Business planning leadership in highly cross-functional team.